CIK 0000849146 · Accelerated filer<br>Smaller reporting company
Lifevantage Corp
Sign in to watch- Ticker
- LFVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 900224471
- Phone
- 801-432-9000
- Business address
- 3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
- Former names
- LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
- Open-market buys, last 90 days
- $6,071
- in 1 filing
- Open-market sales, last 90 days
- $55,649
- in 1 filing
Net −$49,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-31 | Boyster Julie Chief Marketing Officer | Option exercise | +27,966 | 175,216 | ||
| 2025-08-31 | Boyster Julie Chief Marketing Officer | Shares withheld for taxes | −23,293 | $13.10 | $305K | 151,923 |
| 2025-08-31 | Boyster Julie Chief Marketing Officer | Option exercise · Performance Restricted Stock Units | −18,934 | 6,312 | ||
| 2025-08-31 | Boyster Julie Chief Marketing Officer | Option exercise · Performance Restricted Stock Units | −27,966 | 13,983 | ||
| 2025-08-26 | Neufeld Alissa General Counsel | Grant or award | +9,036 | 100,605 | ||
| 2025-08-26 | Neufeld Alissa General Counsel | Grant or award · Performance Restricted Stock Units | +13,554 | 13,554 | ||
| 2025-08-26 | Boyster Julie Chief Marketing Officer | Grant or award | +13,102 | 128,316 | ||
| 2025-08-26 | Boyster Julie Chief Marketing Officer | Grant or award · Performance Restricted Stock Units | +19,654 | 19,654 | ||
| 2025-08-26 | Fife Steven R President and CEO | Grant or award | +48,193 | 659,500 | ||
| 2025-08-26 | Fife Steven R President and CEO | Grant or award · Performance Restricted Stock Units | +72,289 | 72,289 | ||
| 2025-08-26 | Cunningham Kristen Chief Sales Officer | Grant or award | +12,349 | 116,351 | ||
| 2025-08-26 | Cunningham Kristen Chief Sales Officer | Grant or award · Performance Restricted Stock Units | +18,524 | 18,524 | ||
| 2025-08-26 | Aure Carl Chief Financial Officer | Grant or award | +10,241 | 143,544 | ||
| 2025-08-26 | Aure Carl Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +15,361 | 15,361 | ||
| 2025-07-01 | Aure Carl Chief Financial Officer | Option exercise | +2,401 | 136,049 | ||
| 2025-07-01 | Aure Carl Chief Financial Officer | Sale | −2,746 | $13.39 | $37K | 133,303 |
| 2025-07-01 | Aure Carl Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −2,401 | 0 | ||
| 2025-07-01 | Fife Steven R President and CEO | Shares withheld for taxes | −21,064 | $13.39 | $282K | 611,307 |
| 2025-07-01 | Neufeld Alissa General Counsel | Option exercise | +2,667 | 94,368 | ||
| 2025-07-01 | Neufeld Alissa General Counsel | Shares withheld for taxes | −2,799 | $13.39 | $37K | 91,569 |
Page 5 of 10 · 193 trades